Alex Thompson Analyst Performance

Managing Director Biotechnology at Stifel Nicolaus

Alex Thompson is a stock analyst at Stifel Nicolaus in the medical sector, covering 9 publicly traded companies. Over the past year, Alex Thompson has issued 10 stock ratings, including buy and hold recommendations. While full access to Alex Thompson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Alex Thompson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 10 Last 0 Years
Buy Recommendations: 66.67% 6 Buy Ratings
Companies Covered: 9 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	66.7%	6 ratings
Hold	33.3%	3 ratings
Sell	0.0%	0 ratings

Out of 9 total stock ratings issued by Alex Thompson at Stifel Nicolaus, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	9 companies

Alex Thompson, an analyst at Stifel Nicolaus, currently covers 9 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 9 companies	100.0%

Alex Thompson of Stifel Nicolaus specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 7 companies	77.8%
MED - DRUGS 2 companies	22.2%

About Alex Thompson

Alex Thompson, PhD joined Stifel in 2019. Alex is a Managing Director covering stocks in the Biotechnology Sector and is based out of Boston, MA. Alex previously worked as an Associate Vice President with Paul Matteis covering SMID cap biotech at Stifel. Prior to joining Stifel, Alex worked as a consultant at ClearView Healthcare Partners, a consulting firm focused on life sciences strategy. Before ClearView, Alex earned a PhD at Yale University in organic chemistry where he developed new strategies for live-cell super resolution microscopy. While at Yale, Alex published multiple first author papers in high profile journals including Nature Biotechnology. Alex earned a BA in chemistry from Hamilton College.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ARGX argenex	9/18/2025	Set Price Target	$731.77	$882.00
DNTH Dianthus Therapeutics	9/12/2025	Boost Price Target	$36.45	$65.00	Buy
TVTX Travere Therapeutics	9/12/2025	Boost Price Target	$24.50	$25.00	Hold
ASND Ascendis Pharma A/S	8/8/2025	Boost Price Target	$183.02	$254.00	Buy
CGEM Cullinan Therapeutics	6/11/2025	Initiated Coverage	$9.00	$22.00	Buy
KYMR Kymera Therapeutics	5/20/2025	Initiated Coverage	$30.26	$55.00	Buy
TVTX Travere Therapeutics	5/2/2025	Boost Price Target	$20.61	$23.00	Hold
THRD Third Harmonic Bio	3/28/2025	Reiterated Rating	$3.49	$5.00	Hold
AVTX Avalo Therapeutics	3/25/2025	Initiated Coverage	$7.63	$36.00	Buy
CRNX Crinetics Pharmaceuticals	3/25/2025	Initiated Coverage	$35.94	$60.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.